Caligan Partners as of Dec. 31, 2022
Portfolio Holdings for Caligan Partners
Caligan Partners holds 11 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Liquidia Corp Com New (LQDA) | 51.4 | $65M | 10M | 6.37 | |
| Anika Therapeutics (ANIK) | 13.9 | $18M | 592k | 29.60 | |
| Evolus (EOLS) | 10.4 | $13M | 1.7M | 7.51 | |
| Adma Biologics (ADMA) | 8.2 | $10M | 2.7M | 3.88 | |
| D Fluidigm Corp Del (LAB) | 8.0 | $10M | 8.6M | 1.17 | |
| Verona Pharma Sponsored Ads (VRNA) | 3.8 | $4.8M | 183k | 26.13 | |
| Recro Pharma | 1.9 | $2.4M | 1.6M | 1.49 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 1.2 | $1.5M | 435k | 3.50 | |
| Alimera Sciences Com New | 1.0 | $1.3M | 479k | 2.71 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.1 | $159k | 1.0k | 159.31 | |
| Agios Pharmaceuticals (AGIO) | 0.1 | $122k | 4.3k | 28.08 |
